HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Interdisciplinary Care and Hot Topics in Movement Disorders: Jill Farmer, DO, MPH

The director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute discussed the importance of a multidisciplinary approach to movement disorders and the hot topics of conversation at ATMRD. [WATCH TIME: 2 minutes]

WATCH TIME: 2 minutes

“No one can be an expert in everything. You’ll have a doctor or an APP [as] somebody taking over the clinical role in conjunction with somebody who’s going to be dealing with the social issues, like a social worker or a therapist, and someone who’s going to be taking care of the rehab strategies.”

This year, the PMD Alliance, in collaboration with Georgetown University Hospital, put on the first annual Advanced Therapeutics in Movement and Related Disorders (ATMRD) Congress in Washington, DC, June 17-19, 2022. The meeting was open to all clinicians and care team members, with a specific focus on advanced practice providers (APPs) and other nonphysician individuals—a reflection of the real-world interdisciplinary care that occurs for these patients.

Jill Farmer, DO, MPH, assistant professor of neurology, and director, Parkinson’s Disease and Movement Disorder Program, Global Neuroscience Institute, spoke to the PMD Alliance about the importance of an interdisciplinary care team for this patient population. Notably, she offered the perspective of not only the complex care required for these patients but the varying areas of expertise brought to the team by each member. As she said, “No one can be an expert in everything.”

Interdisciplinary, or multidisciplinary, care has been a hot topic of conversation in the field for quite some time. However, Farmer also spoke to some of the other topics driving the conversation, particularly those about the future of care, including the ideal therapeutic targets and approaches that can modify disease for patients.

Click here for more coverage of ATMRD 2022